Ceftriaxone versus ampicillin for the treatment of community-acquired pneumonia. A propensity matched cohort study - PubMed
Ampicillin was associated with comparable clinical outcomes in comparison to ceftriaxone for patients who were hospitalized due to CAP. Ampicillin was associated with significantly lower rate of CDI. Results need to be confirmed by more robust study designs.